This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,741.62 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The contract has an ultimate completion date of November 18, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is made under that larger IDC contract. The contract does not have a set-aside designation, indicating open competition. As a major supplier of medical products to federal agencies, AmerisourceBergen plays a critical role in supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/16/25, 9:01 AM